EUVIMEDEUVIMED entdecken
Crossref

Comment on ‘Fisher–Schultz Lecture: Contracting Over Pharmaceutical Formularies and Rebates’ by Kate Ho and Robin Lee

Rena M. Conti

Econometrica · 2026 · 94 (3) · 729-733

DOI: 10.3982/ecta24210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Econometrica, 2026. Verfasst von Rena M. Conti. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biopharmaceuticals advance health and economic growth. Unlike central bargaining abroad, the United States uses private firms, pharmacy benefit managers (PBMs), to manage medicine access and spending. Yet, PBMs' roles in advancing efficiency are understudied. Ho and Lee model PBMs' use of tiered formularies, lists of covered medicines, without the use of proprietary data on the price concessions drug makers offer for preferred placement. They find PBMs' use of tiered formularies generate significant payor savings through competition. Complementing Ho and Lee, Feng and Maini (2024) model how patient demand inertia limits PBMs' ability to extract price concessions from drug makers which consequently erodes the efficacy gains of PBM formularies. Conti, Frandsen, Powell, and Rebitzer (2021) model formulary auctions where PBM size drives payor savings, but also spurs endogenously set high list prices, reducing patient access. Future economic research should focus on PBM market entry and vertical integration, pharmacy steering, and effects on innovation.

Zitieren

APA

Conti, R. M. (2026). Comment on ‘Fisher–Schultz Lecture: Contracting Over Pharmaceutical Formularies and Rebates’ by Kate Ho and Robin Lee. Econometrica, 94(3), 729-733. https://doi.org/10.3982/ecta24210

Vancouver

Conti RM. Comment on ‘Fisher–Schultz Lecture: Contracting Over Pharmaceutical Formularies and Rebates’ by Kate Ho and Robin Lee. Econometrica. 2026;94(3):729-733. doi:10.3982/ecta24210

BibTeX
@article{Conti2026,
  author = {Conti, Rena M.},
  title = {Comment on ‘Fisher–Schultz Lecture: Contracting Over Pharmaceutical Formularies and Rebates’ by Kate Ho and Robin Lee},
  journal = {Econometrica},
  year = {2026},
  volume = {94},
  number = {3},
  pages = {729--733},
  doi = {10.3982/ecta24210}
}
Kostenlos starten →